Gene · 5469
Papers2,516
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,516
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bivalent activity of super-enhancer RNA LINC02454 controls 3D chromatin structure and regulates glioma sensitivity to temozolomide. | Cell Death Dis | 2024 | 38177123 | PubTator, text mining | PubMed |
| Deciphering the emerging landscape of HOX genes in cardiovascular biology, atherosclerosis and beyond (Review). | Int J Mol Med | 2024 | 38131178 | PubTator, text mining | PubMed |
| Exploring the Spatial Landscape of the Estrogen Receptor Proximal Proteome With Antibody-Based Proximity Labeling. | Mol Cell Proteomics | 2024 | 38122900 | PubTator, text mining | PubMed |
| Profiling of secondary metabolite and evaluation of anti-diabetic potency of Crotalaria quinquefolia (L): In-vitro, in-vivo, and in-silico approaches. | Saudi Pharm J | 2024 | 38090734 | PubTator, text mining | PubMed |
| KMT2D preferentially binds mRNAs of the genes it regulates, suggesting a role in RNA processing. | Protein Sci | 2024 | 38058280 | PubTator, text mining | PubMed |
| CYTOR Facilitates Formation of FOSL1 Phase Separation and Super Enhancers to Drive Metastasis of Tumor Budding Cells in Head and Neck Squamous Cell Carcinoma. | Adv Sci (Weinh) | 2024 | 38032139 | PubTator, text mining | PubMed |
| Chromatin accessibility and pioneer factor FOXA1 restrict glucocorticoid receptor action in prostate cancer. | Nucleic Acids Res | 2024 | 38015476 | PubTator, text mining | PubMed |
| Mediator Subunit Med4 Enforces Metastatic Dormancy in Breast Cancer. | bioRxiv | 2024 | 38014033 | PubTator, text mining | PubMed |
| DriverDBv4: a multi-omics integration database for cancer driver gene research. | Nucleic Acids Res | 2024 | 37956338 | PubTator, text mining | PubMed |
| ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma. | Blood Cancer Discov | 2024 | 37934799 | PubTator, text mining | PubMed |
| Somatic estrogen receptor α mutations that induce dimerization promote receptor activity and breast cancer proliferation. | J Clin Invest | 2024 | 37883178 | PubTator, text mining | PubMed |
| Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma. | Blood Cancer Discov | 2024 | 37767768 | PubTator, text mining | PubMed |
| Dysfunction of autophagy in high-fat diet-induced non-alcoholic fatty liver disease. | Autophagy | 2024 | 37700498 | PubTator, text mining | PubMed |
| Global miRNA profiling reveals key molecules that contribute to different chronic lymphocytic leukemia incidences in Asian and Western populations. | Haematologica | 2024 | 37646669 | PubTator, text mining | PubMed |
| Management Challenges of Extrapulmonary Nontuberculous Mycobacterial Infection: A Single-Center Case Series and Literature Review. | Pathogens | 2023 | 38276158 | PubTator, text mining | PubMed |
| The Role of microRNA in Spermatogenesis: Is There a Place for Fertility Preservation Innovation? | Int J Mol Sci | 2023 | 38203631 | PubTator, text mining | PubMed |
| Multiomics insights on the onset, progression, and metastatic evolution of breast cancer. | Front Oncol | 2023 | 38169859 | PubTator, text mining | PubMed |
| Super-enhancers and the super-enhancer reader BRD4: tumorigenic factors and therapeutic targets. | Cell Death Discov | 2023 | 38135679 | PubTator, text mining | PubMed |
| Phase Separation as a Driver of Stem Cell Organization and Function during Development. | J Dev Biol | 2023 | 38132713 | PubTator, text mining | PubMed |
| Phase separations in oncogenesis, tumor progressions and metastasis: a glance from hallmarks of cancer. | J Hematol Oncol | 2023 | 38110976 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5469/papers?page=7